Carole Ho - Feb 15, 2023 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Feb 15, 2023
Transactions value $
-$43,394
Form type
4
Date filed
2/17/2023, 03:20 PM
Previous filing
Feb 14, 2023
Next filing
May 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$43.4K -1.48K -0.8% $29.40 183K Feb 15, 2023 See footnote F1, F2
holding DNLI Common Stock 25K Feb 15, 2023 See footnote F3
holding DNLI Common Stock 120K Feb 15, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F3 The shares are held of record by the Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 Includes 119,339 RSUs.